Related Experiment Video
Updated: Apr 16, 2026

Determination of In Vitro and Cellular Turn-on Kinetics for Fluorogenic RNA Aptamers
Published on: August 9, 2022
DICER-ARGONAUTE2 complex in continuous fluorogenic assays of RNA interference enzymes
Mark A Bernard1, Leyu Wang2, Souvenir D Tachado3
1Department of Target Biology, Pfizer Oligonucleotide Therapeutics Unit, Cambridge South Campus, Cambridge, Massachusetts, United States of America; Department of Protein Biology, Pfizer Global Biotherapeutics Technology Unit, Cambridge North Campus, Cambridge, Massachusetts, United States of America; Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.
New fluorogenic substrates enable continuous monitoring of RNA-Induced Silencing Complex (RISC) enzyme activity. This reveals synergistic activity between DICER and ARGONAUTE2 (AGO2) enzymes, crucial for optimizing RNA interference therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- RNA Biology
Background:
- Studying RNA processing within the RNA-Induced Silencing Complex (RISC) is vital for understanding gene regulation.
- Previous methods lacked continuous monitoring capabilities, hindering detailed kinetic studies of RISC enzymatic activity.
Purpose of the Study:
- To develop and utilize "quencherless" fluorogenic substrates for continuous monitoring of RNAi enzyme kinetics.
- To elucidate the synergistic enzymatic activity and complex formation between DICER and ARGONAUTE2 (AGO2) within the RISC pathway.
Main Methods:
- Employed "quencherless" fluorogenic substrates for DICER and siRNA processing.
- Utilized recombinant RISC enzymes, including DICER and AGO2, in in vitro assays.
- Performed enzyme kinetics studies, including Michaelis-Menten and substrate inhibition analyses.
- Correlated in vitro substrate processing with cell-based mRNA knockdown assays.
Main Results:
- DICER and AGO2 exhibit synergistic enzymatic activity, forming a high-affinity complex in an equimolar ratio.
- AGO2 requires DICER for siRNA processing, indicating DICER's role in AGO2-loading.
- Demonstrated substrate inhibition kinetics for DICER+AGO2 processing of siRNA, suggesting dual binding sites.
- Optimized DICER substrates showed a significant improvement in mRNA knockdown efficacy.
Conclusions:
- Developed a robust biochemical assay for studying RISC enzyme kinetics.
- Established the functional interaction and complex formation between DICER and AGO2.
- Provided a foundation for designing improved nucleic acid-based therapeutics targeting RISC for enhanced efficacy.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
Real Time RT-PCR
The real-time quantification of the number of amplified products is...

